Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Vaccine Elicitation of HIV Broadly Neutralizing Antibodies from Engineered B cells

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.03.17.989699Source: DataRank Database

Vaccine Elicitation of HIV Broadly Neutralizing Antibodies from Engineered B cells is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2020). On theSindex it has a DataRank of 0. It has been cited 23 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access23 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: greenTopics (40)IDs (PubMed, OpenAlex)SDGs (3)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (20)

Jenny Tuyet Tran,Alex Olson ORCID,Thomas Vollbrecht ORCID,Mariia V. Guryleva ORCID,Mary Tenuta ORCID

Live enrichment

PubMed:19767382 OpenAlex:https://openalex.org/W3011641153

National Institutes of Health

Grant: 5R01AI073148-13

Knock-in mice expressing germline-reverted broadly neutralizing HIV antibodies

National Institutes of Health

Grant: 5R01DE025167-03

Genomic modification with purified nuclease proteins for HIV-1 therapy

National Institutes of Health

Grant: 5R01DE025167-05

Genomic modification with purified nuclease proteins for HIV-1 therapy

National Institutes of Health

Grant: 1R01AI128836-01

Designing and optimizing candidate HIV vaccines and boosting protocols

greenLicense: cc-by-nc-nd

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2020/03/17/2020.03.17.989699.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2020.03.17.989699

repositoryhttps://doi.org/10.1101/2020.03.17.989699

repositoryhttps://www.nature.com/articles/s41467-020-19650-8

Fields of Study

HIV Research and TreatmentImmune Cell Function and InteractionT-cell and B-cell Immunology0301 basic medicine03 medical and health sciences0303 health sciences

Keywords

Somatic hypermutationAntibodyBiologyVirologyGenetically engineeredB cellImmunizationViremiaNeutralizing antibodyImmunologyTransduction (biophysics)GeneGeneticsScienceHIV InfectionsHIV AntibodiesLymphocyte ActivationArticleGene therapyAnimalsHumansAIDS VaccinesVaccinesB-LymphocytesQAntibodies, MonoclonalMice, Inbred C57BLHumoral immunityHEK293 CellsFemaleSomatic Hypermutation, ImmunoglobulinGenetic EngineeringImmunologic MemoryBroadly Neutralizing Antibodies

Sustainable Development Goals

SDG 3: 3. Good healthSDG 16: 16. Peace & justiceSDG 0: Good health and well-being